PDB Short entry for 5L2W HEADER TRANSFERASE/CELL CYCLE/INHIBITOR 02-AUG-16 5L2W TITLE THE X-RAY CO-CRYSTAL STRUCTURE OF HUMAN CDK2/CYCLINE AND DINACICLIB. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2,P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: G1/S-SPECIFIC CYCLIN-E1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 81-363; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCNE1, CCNE; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CYCLIN-DEPENDENT KINASE, KINASE INHIBITOR, KINASE SELECTIVITY, KEYWDS 2 TRANSFERASE-CELL CYCLE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.CHEN,R.A.FERRE,W.DEIHL,X.YU,Y.-A.HE REVDAT 3 04-OCT-23 5L2W 1 REMARK REVDAT 2 19-OCT-16 5L2W 1 JRNL REVDAT 1 24-AUG-16 5L2W 0 JRNL AUTH P.CHEN,N.V.LEE,W.HU,M.XU,R.A.FERRE,H.LAM,S.BERGQVIST, JRNL AUTH 2 J.SOLOWIEJ,W.DIEHL,Y.A.HE,X.YU,A.NAGATA,T.VANARSDALE, JRNL AUTH 3 B.W.MURRAY JRNL TITL SPECTRUM AND DEGREE OF CDK DRUG INTERACTIONS PREDICTS JRNL TITL 2 CLINICAL PERFORMANCE. JRNL REF MOL.CANCER THER. V. 15 2273 2016 JRNL REFN ESSN 1538-8514 JRNL PMID 27496135 JRNL DOI 10.1158/1535-7163.MCT-16-0300 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19741 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 962 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.95 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2828 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2501 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2699 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.3483 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.56 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 129 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4617 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 100.2 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 84.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.10780 REMARK 3 B22 (A**2) : -6.10780 REMARK 3 B33 (A**2) : 12.21560 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.378 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 2.166 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.335 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.334 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.337 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4774 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6482 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1661 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 109 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 693 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4774 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 604 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5661 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.72 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.34 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5L2W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223112. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 98.15 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19770 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.76 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 1W98 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, 180MM MG(HCO2)2, 0.1M MES PH REMARK 280 6.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 286.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.92850 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 50.15350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 50.15350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.96425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 50.15350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 50.15350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 113.89275 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 50.15350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.15350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.96425 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 50.15350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.15350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 113.89275 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 75.92850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23440 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 298 REMARK 465 MET B 57 REMARK 465 ALA B 58 REMARK 465 SER B 59 REMARK 465 HIS B 60 REMARK 465 HIS B 61 REMARK 465 HIS B 62 REMARK 465 HIS B 63 REMARK 465 HIS B 64 REMARK 465 HIS B 65 REMARK 465 ASP B 66 REMARK 465 TYR B 67 REMARK 465 ASP B 68 REMARK 465 GLY B 69 REMARK 465 ALA B 70 REMARK 465 THR B 71 REMARK 465 THR B 72 REMARK 465 GLU B 73 REMARK 465 ASN B 74 REMARK 465 LEU B 75 REMARK 465 TYR B 76 REMARK 465 PHE B 77 REMARK 465 GLN B 78 REMARK 465 GLY B 79 REMARK 465 SER B 80 REMARK 465 ILE B 81 REMARK 465 ILE B 82 REMARK 465 ALA B 83 REMARK 465 PRO B 84 REMARK 465 SER B 85 REMARK 465 ARG B 86 REMARK 465 GLY B 87 REMARK 465 ALA B 358 REMARK 465 ARG B 359 REMARK 465 ALA B 360 REMARK 465 LYS B 361 REMARK 465 LYS B 362 REMARK 465 ALA B 363 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 12 -64.47 -108.67 REMARK 500 THR A 72 53.30 -113.36 REMARK 500 GLU A 73 33.91 34.86 REMARK 500 ASN A 74 -30.62 -171.45 REMARK 500 ARG A 126 15.83 59.18 REMARK 500 ASP A 127 52.89 -158.99 REMARK 500 ASP A 145 87.67 50.27 REMARK 500 GLU A 162 70.75 -69.45 REMARK 500 SER A 181 -147.78 -152.57 REMARK 500 ASP A 288 -60.23 -91.90 REMARK 500 HIS B 117 45.96 -106.64 REMARK 500 GLU B 166 -68.88 -106.16 REMARK 500 SER B 227 59.98 -115.04 REMARK 500 TYR B 243 74.00 -109.30 REMARK 500 HIS B 248 69.55 -66.19 REMARK 500 VAL B 274 1.32 -60.23 REMARK 500 SER B 293 -114.20 -121.58 REMARK 500 ASP B 350 37.04 -71.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1042 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH B 431 DISTANCE = 7.26 ANGSTROMS REMARK 525 HOH B 432 DISTANCE = 10.47 ANGSTROMS REMARK 525 HOH B 433 DISTANCE = 13.83 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1QK A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5L2T RELATED DB: PDB REMARK 900 RELATED ID: 5L2S RELATED DB: PDB REMARK 900 RELATED ID: 5L2I RELATED DB: PDB DBREF 5L2W A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 5L2W B 81 363 UNP P24864 CCNE1_HUMAN 81 363 SEQADV 5L2W SER A 0 UNP P24941 EXPRESSION TAG SEQADV 5L2W MET B 57 UNP P24864 INITIATING METHIONINE SEQADV 5L2W ALA B 58 UNP P24864 EXPRESSION TAG SEQADV 5L2W SER B 59 UNP P24864 EXPRESSION TAG SEQADV 5L2W HIS B 60 UNP P24864 EXPRESSION TAG SEQADV 5L2W HIS B 61 UNP P24864 EXPRESSION TAG SEQADV 5L2W HIS B 62 UNP P24864 EXPRESSION TAG SEQADV 5L2W HIS B 63 UNP P24864 EXPRESSION TAG SEQADV 5L2W HIS B 64 UNP P24864 EXPRESSION TAG SEQADV 5L2W HIS B 65 UNP P24864 EXPRESSION TAG SEQADV 5L2W ASP B 66 UNP P24864 EXPRESSION TAG SEQADV 5L2W TYR B 67 UNP P24864 EXPRESSION TAG SEQADV 5L2W ASP B 68 UNP P24864 EXPRESSION TAG SEQADV 5L2W GLY B 69 UNP P24864 EXPRESSION TAG SEQADV 5L2W ALA B 70 UNP P24864 EXPRESSION TAG SEQADV 5L2W THR B 71 UNP P24864 EXPRESSION TAG SEQADV 5L2W THR B 72 UNP P24864 EXPRESSION TAG SEQADV 5L2W GLU B 73 UNP P24864 EXPRESSION TAG SEQADV 5L2W ASN B 74 UNP P24864 EXPRESSION TAG SEQADV 5L2W LEU B 75 UNP P24864 EXPRESSION TAG SEQADV 5L2W TYR B 76 UNP P24864 EXPRESSION TAG SEQADV 5L2W PHE B 77 UNP P24864 EXPRESSION TAG SEQADV 5L2W GLN B 78 UNP P24864 EXPRESSION TAG SEQADV 5L2W GLY B 79 UNP P24864 EXPRESSION TAG SEQADV 5L2W SER B 80 UNP P24864 EXPRESSION TAG SEQRES 1 A 299 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 A 299 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 A 299 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 A 299 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 A 299 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 A 299 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 A 299 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 A 299 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 A 299 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 A 299 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 A 299 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 A 299 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 A 299 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 A 299 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 A 299 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 A 299 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 A 299 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 A 299 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 A 299 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 A 299 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 A 299 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 A 299 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 A 299 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 307 MET ALA SER HIS HIS HIS HIS HIS HIS ASP TYR ASP GLY SEQRES 2 B 307 ALA THR THR GLU ASN LEU TYR PHE GLN GLY SER ILE ILE SEQRES 3 B 307 ALA PRO SER ARG GLY SER PRO LEU PRO VAL LEU SER TRP SEQRES 4 B 307 ALA ASN ARG GLU GLU VAL TRP LYS ILE MET LEU ASN LYS SEQRES 5 B 307 GLU LYS THR TYR LEU ARG ASP GLN HIS PHE LEU GLU GLN SEQRES 6 B 307 HIS PRO LEU LEU GLN PRO LYS MET ARG ALA ILE LEU LEU SEQRES 7 B 307 ASP TRP LEU MET GLU VAL CYS GLU VAL TYR LYS LEU HIS SEQRES 8 B 307 ARG GLU THR PHE TYR LEU ALA GLN ASP PHE PHE ASP ARG SEQRES 9 B 307 TYR MET ALA THR GLN GLU ASN VAL VAL LYS THR LEU LEU SEQRES 10 B 307 GLN LEU ILE GLY ILE SER SER LEU PHE ILE ALA ALA LYS SEQRES 11 B 307 LEU GLU GLU ILE TYR PRO PRO LYS LEU HIS GLN PHE ALA SEQRES 12 B 307 TYR VAL THR ASP GLY ALA CYS SER GLY ASP GLU ILE LEU SEQRES 13 B 307 THR MET GLU LEU MET ILE MET LYS ALA LEU LYS TRP ARG SEQRES 14 B 307 LEU SER PRO LEU THR ILE VAL SER TRP LEU ASN VAL TYR SEQRES 15 B 307 MET GLN VAL ALA TYR LEU ASN ASP LEU HIS GLU VAL LEU SEQRES 16 B 307 LEU PRO GLN TYR PRO GLN GLN ILE PHE ILE GLN ILE ALA SEQRES 17 B 307 GLU LEU LEU ASP LEU CYS VAL LEU ASP VAL ASP CYS LEU SEQRES 18 B 307 GLU PHE PRO TYR GLY ILE LEU ALA ALA SER ALA LEU TYR SEQRES 19 B 307 HIS PHE SER SER SER GLU LEU MET GLN LYS VAL SER GLY SEQRES 20 B 307 TYR GLN TRP CYS ASP ILE GLU ASN CYS VAL LYS TRP MET SEQRES 21 B 307 VAL PRO PHE ALA MET VAL ILE ARG GLU THR GLY SER SER SEQRES 22 B 307 LYS LEU LYS HIS PHE ARG GLY VAL ALA ASP GLU ASP ALA SEQRES 23 B 307 HIS ASN ILE GLN THR HIS ARG ASP SER LEU ASP LEU LEU SEQRES 24 B 307 ASP LYS ALA ARG ALA LYS LYS ALA MODRES 5L2W TPO A 160 THR MODIFIED RESIDUE HET TPO A 160 11 HET 1QK A 900 29 HET GOL A 901 6 HETNAM TPO PHOSPHOTHREONINE HETNAM 1QK 3-[({3-ETHYL-5-[(2S)-2-(2-HYDROXYETHYL)PIPERIDIN-1- HETNAM 2 1QK YL]PYRAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)METHYL]-1- HETNAM 3 1QK HYDROXYPYRIDINIUM HETNAM GOL GLYCEROL HETSYN TPO PHOSPHONOTHREONINE HETSYN 1QK DINACICLIB HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 1QK C21 H29 N6 O2 1+ FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *75(H2 O) HELIX 1 AA1 PRO A 45 LYS A 56 1 12 HELIX 2 AA2 LEU A 87 SER A 94 1 8 HELIX 3 AA3 PRO A 100 HIS A 121 1 22 HELIX 4 AA4 LYS A 129 GLN A 131 5 3 HELIX 5 AA5 THR A 165 ARG A 169 5 5 HELIX 6 AA6 ALA A 170 LEU A 175 1 6 HELIX 7 AA7 THR A 182 ARG A 199 1 18 HELIX 8 AA8 SER A 207 GLY A 220 1 14 HELIX 9 AA9 GLY A 229 MET A 233 5 5 HELIX 10 AB1 ASP A 247 VAL A 252 1 6 HELIX 11 AB2 ASP A 256 LEU A 267 1 12 HELIX 12 AB3 SER A 276 ALA A 282 1 7 HELIX 13 AB4 HIS A 283 GLN A 287 5 5 HELIX 14 AB5 ASN B 97 TYR B 112 1 16 HELIX 15 AB6 GLN B 126 TYR B 144 1 19 HELIX 16 AB7 HIS B 147 ALA B 163 1 17 HELIX 17 AB8 THR B 171 GLU B 189 1 19 HELIX 18 AB9 LYS B 194 VAL B 201 1 8 HELIX 19 AC1 SER B 207 LEU B 222 1 16 HELIX 20 AC2 THR B 230 TYR B 243 1 14 HELIX 21 AC3 PRO B 256 LEU B 272 1 17 HELIX 22 AC4 ASP B 275 PHE B 279 5 5 HELIX 23 AC5 PRO B 280 SER B 293 1 14 HELIX 24 AC6 SER B 294 GLY B 303 1 10 HELIX 25 AC7 GLN B 305 GLY B 327 1 23 HELIX 26 AC8 ALA B 338 ILE B 345 5 8 HELIX 27 AC9 ASP B 350 ASP B 356 1 7 SHEET 1 AA1 5 PHE A 4 GLY A 11 0 SHEET 2 AA1 5 VAL A 17 ASN A 23 -1 O LYS A 20 N VAL A 7 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O LEU A 32 N TYR A 19 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O PHE A 80 N ALA A 31 SHEET 5 AA1 5 LEU A 66 HIS A 71 -1 N ILE A 70 O TYR A 77 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AA3 2 VAL A 123 LEU A 124 0 SHEET 2 AA3 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.36 LINK C TPO A 160 N HIS A 161 1555 1555 1.35 CISPEP 1 VAL A 154 PRO A 155 0 5.85 SITE 1 AC1 11 ILE A 10 ALA A 31 PHE A 80 GLU A 81 SITE 2 AC1 11 PHE A 82 LEU A 83 HIS A 84 GLN A 85 SITE 3 AC1 11 LYS A 89 LEU A 134 ALA A 144 SITE 1 AC2 4 HIS A 84 TYR A 107 ASN A 136 GLY A 139 CRYST1 100.307 100.307 151.857 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009969 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009969 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006585 0.00000